Teva Will Try Again To Get FDA Approval On Epipen Competitor, By 2018

Teva Will Try Again To Get FDA Approval On Epipen Competitor, By 2018

The price of the EpiPen emergency allergy medication soared by 400% to 600% over the last decade, in part due to a lack of competition. In February, the FDA rejected a potential competing injector from Teva Pharmaceuticals, but now the company says it still hopes to get an EpiPen alternative in pharmacies — at some point in the next two years.  [More]

Teva Pharmaceuticals: The Ubiquitous Company You've Never Heard Of

Teva Pharmaceuticals: The Ubiquitous Company You've Never Heard Of

Generic prescription drugs are just that: generic. Most patients don’t think much about who actually manufactures them. It’s pretty likely, however, that you have something in your medicine cabinet manufactured by Israel’s Teva Pharmaceutical Industries Ltd. A profile of the company in this past weekend’s New York Times is fascinating. Most interesting of all: while the company is sensibly frugal enough to make Captain Moneycat purr, they refuse to move manufacturing to China or India, as many of their competitors have.

[More]